These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 33861434)
1. The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. Mirhafez SR; Azimi-Nezhad M; Dehabeh M; Hariri M; Naderan RD; Movahedi A; Abdalla M; Sathyapalan T; Sahebkar A Adv Exp Med Biol; 2021; 1308():25-35. PubMed ID: 33861434 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial. Rahmani S; Asgary S; Askari G; Keshvari M; Hatamipour M; Feizi A; Sahebkar A Phytother Res; 2016 Sep; 30(9):1540-8. PubMed ID: 27270872 [TBL] [Abstract][Full Text] [Related]
3. The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. Saadati S; Hatami B; Yari Z; Shahrbaf MA; Eghtesad S; Mansour A; Poustchi H; Hedayati M; Aghajanpoor-Pasha M; Sadeghi A; Hekmatdoost A Eur J Clin Nutr; 2019 Mar; 73(3):441-449. PubMed ID: 30610213 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: A double-blind, randomized, placebo-controlled clinical trial. Sharifi S; Bagherniya M; Khoram Z; Ebrahimi Varzaneh A; Atkin SL; Jamialahmadi T; Sahebkar A; Askari G Phytother Res; 2023 Jun; 37(6):2217-2229. PubMed ID: 36799355 [TBL] [Abstract][Full Text] [Related]
5. Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Mirhafez SR; Farimani AR; Dehhabe M; Bidkhori M; Hariri M; Ghouchani BF; Abdollahi F J Gastrointestin Liver Dis; 2019 Jun; 28():183-189. PubMed ID: 31204416 [TBL] [Abstract][Full Text] [Related]
6. Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial. Namkhah Z; Naeini F; Mahdi Rezayat S; Mehdi Yaseri ; Mansouri S; Javad Hosseinzadeh-Attar M Int J Clin Pract; 2021 Nov; 75(11):e14852. PubMed ID: 34516703 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial. Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A Drug Res (Stuttg); 2017 Apr; 67(4):244-251. PubMed ID: 28158893 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J Front Immunol; 2022; 13():949746. PubMed ID: 36159792 [TBL] [Abstract][Full Text] [Related]
9. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492 [TBL] [Abstract][Full Text] [Related]
10. Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Mansour A; Mohajeri-Tehrani MR; Samadi M; Qorbani M; Merat S; Adibi H; Poustchi H; Hekmatdoost A Nutr J; 2021 Apr; 20(1):35. PubMed ID: 33838673 [TBL] [Abstract][Full Text] [Related]
11. The Effect of Zinc Supplementation on Steatosis Severity and Liver Function Enzymes in Overweight/Obese Patients with Mild to Moderate Non-alcoholic Fatty Liver Following Calorie-Restricted Diet: a Double-Blind, Randomized Placebo-Controlled Trial. Fathi M; Alavinejad P; Haidari Z; Amani R Biol Trace Elem Res; 2020 Oct; 197(2):394-404. PubMed ID: 32020523 [TBL] [Abstract][Full Text] [Related]
12. Curcumin and Piperine Combination for the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled Trial. Mirhafez SR; Dehabeh M; Hariri M; Farimani AR; Movahedi A; Naderan RD; Jamialahmadi T; Simental-Mendía LE; Sahebkar A Adv Exp Med Biol; 2021; 1328():11-19. PubMed ID: 34981468 [TBL] [Abstract][Full Text] [Related]
13. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial. Sangouni AA; Mohammad Hosseini Azar MR; Alizadeh M Br J Nutr; 2020 Aug; 124(4):450-456. PubMed ID: 32312333 [TBL] [Abstract][Full Text] [Related]
14. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials. Goodarzi R; Sabzian K; Shishehbor F; Mansoori A Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773 [TBL] [Abstract][Full Text] [Related]
15. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial. Izadi F; Farrokhzad A; Tamizifar B; Tarrahi MJ; Entezari MH Phytother Res; 2021 Jan; 35(1):477-485. PubMed ID: 32909326 [TBL] [Abstract][Full Text] [Related]
16. A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial. Hariri M; Gholami A; Mirhafez SR; Bidkhori M; Sahebkar A Complement Ther Med; 2020 Jun; 51():102447. PubMed ID: 32507446 [TBL] [Abstract][Full Text] [Related]
17. Effects of curcumin/turmeric supplementation on the liver enzymes, lipid profiles, glycemic index, and anthropometric indices in non-alcoholic fatty liver patients: An umbrella meta-analysis. Molani-Gol R; Dehghani A; Rafraf M Phytother Res; 2024 Feb; 38(2):539-555. PubMed ID: 37918958 [TBL] [Abstract][Full Text] [Related]
18. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial. Cicero AFG; Sahebkar A; Fogacci F; Bove M; Giovannini M; Borghi C Eur J Nutr; 2020 Mar; 59(2):477-483. PubMed ID: 30796508 [TBL] [Abstract][Full Text] [Related]
19. Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. Loomba R; Morgan E; Watts L; Xia S; Hannan LA; Geary RS; Baker BF; Bhanot S Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):829-838. PubMed ID: 32553151 [TBL] [Abstract][Full Text] [Related]
20. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial. Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]